Cargando…

Clinicopathological characteristics of resected adenosquamous cell carcinoma of the lung: Risk of coexistent double cancer

BACKGROUND: adenosquamous carcinoma (ADSQ) of non-small cell lung cancer (NSCLC) is a rare disease and the biological behavior and clinicopathological characteristics have not yet been thoroughly described. METHOD: This study reviewed the patient charts of 11 (1.6%) ADSQ cases among 779 patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Uramoto, Hidetaka, Yamada, Sohsuke, Hanagiri, Takeshi
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2987925/
https://www.ncbi.nlm.nih.gov/pubmed/21034441
http://dx.doi.org/10.1186/1749-8090-5-92
_version_ 1782192186948845568
author Uramoto, Hidetaka
Yamada, Sohsuke
Hanagiri, Takeshi
author_facet Uramoto, Hidetaka
Yamada, Sohsuke
Hanagiri, Takeshi
author_sort Uramoto, Hidetaka
collection PubMed
description BACKGROUND: adenosquamous carcinoma (ADSQ) of non-small cell lung cancer (NSCLC) is a rare disease and the biological behavior and clinicopathological characteristics have not yet been thoroughly described. METHOD: This study reviewed the patient charts of 11 (1.6%) ADSQ cases among 779 patients with primary lung cancer who underwent a lung resection. The characteristics and clinicopathological factors were evaluated retrospectively. RESULTS: Six of the 11 patients with ADSQ were male and five were female. The mean age was 67.3 years' olds. Three patients had pathological stage IA, one patient each had stage IB and IIA, five patients had stage IIIA, and one patient stage IIIB. Five patients had coexistent double cancer including 2 gastric, 1 rectal, 1 prostate and 1 bladder cancer. ADSQ was found less frequently in males than squamous cell carcinoma (SQ). ADSQ was found more frequently in older patients, with advanced stage, advanced T status, and lymph node metastases than adenocarcinoma (AD). The proportion with coexistent double cancer of AD, SQ, and ADSQ were 21.1, 17.6, and 45.5%, respectively. ADSQ had a significantly correlation with double cancer (ADSQ vs. non- ADSQ p = 0.03). A multivariate analysis showed no significant prognostic difference between the patients with ADSQ and non- ADSQ. CONCLUSIONS: In this study, cases with ADSQ showed no significantly prognostic difference in comparison to AD and SQ. However, surgeons must be cautious of any coexistent double cancer because approximately half of all patients with ADSQ of the lung have double cancer.
format Text
id pubmed-2987925
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29879252010-11-19 Clinicopathological characteristics of resected adenosquamous cell carcinoma of the lung: Risk of coexistent double cancer Uramoto, Hidetaka Yamada, Sohsuke Hanagiri, Takeshi J Cardiothorac Surg Research Article BACKGROUND: adenosquamous carcinoma (ADSQ) of non-small cell lung cancer (NSCLC) is a rare disease and the biological behavior and clinicopathological characteristics have not yet been thoroughly described. METHOD: This study reviewed the patient charts of 11 (1.6%) ADSQ cases among 779 patients with primary lung cancer who underwent a lung resection. The characteristics and clinicopathological factors were evaluated retrospectively. RESULTS: Six of the 11 patients with ADSQ were male and five were female. The mean age was 67.3 years' olds. Three patients had pathological stage IA, one patient each had stage IB and IIA, five patients had stage IIIA, and one patient stage IIIB. Five patients had coexistent double cancer including 2 gastric, 1 rectal, 1 prostate and 1 bladder cancer. ADSQ was found less frequently in males than squamous cell carcinoma (SQ). ADSQ was found more frequently in older patients, with advanced stage, advanced T status, and lymph node metastases than adenocarcinoma (AD). The proportion with coexistent double cancer of AD, SQ, and ADSQ were 21.1, 17.6, and 45.5%, respectively. ADSQ had a significantly correlation with double cancer (ADSQ vs. non- ADSQ p = 0.03). A multivariate analysis showed no significant prognostic difference between the patients with ADSQ and non- ADSQ. CONCLUSIONS: In this study, cases with ADSQ showed no significantly prognostic difference in comparison to AD and SQ. However, surgeons must be cautious of any coexistent double cancer because approximately half of all patients with ADSQ of the lung have double cancer. BioMed Central 2010-10-29 /pmc/articles/PMC2987925/ /pubmed/21034441 http://dx.doi.org/10.1186/1749-8090-5-92 Text en Copyright ©2010 Uramoto et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Uramoto, Hidetaka
Yamada, Sohsuke
Hanagiri, Takeshi
Clinicopathological characteristics of resected adenosquamous cell carcinoma of the lung: Risk of coexistent double cancer
title Clinicopathological characteristics of resected adenosquamous cell carcinoma of the lung: Risk of coexistent double cancer
title_full Clinicopathological characteristics of resected adenosquamous cell carcinoma of the lung: Risk of coexistent double cancer
title_fullStr Clinicopathological characteristics of resected adenosquamous cell carcinoma of the lung: Risk of coexistent double cancer
title_full_unstemmed Clinicopathological characteristics of resected adenosquamous cell carcinoma of the lung: Risk of coexistent double cancer
title_short Clinicopathological characteristics of resected adenosquamous cell carcinoma of the lung: Risk of coexistent double cancer
title_sort clinicopathological characteristics of resected adenosquamous cell carcinoma of the lung: risk of coexistent double cancer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2987925/
https://www.ncbi.nlm.nih.gov/pubmed/21034441
http://dx.doi.org/10.1186/1749-8090-5-92
work_keys_str_mv AT uramotohidetaka clinicopathologicalcharacteristicsofresectedadenosquamouscellcarcinomaofthelungriskofcoexistentdoublecancer
AT yamadasohsuke clinicopathologicalcharacteristicsofresectedadenosquamouscellcarcinomaofthelungriskofcoexistentdoublecancer
AT hanagiritakeshi clinicopathologicalcharacteristicsofresectedadenosquamouscellcarcinomaofthelungriskofcoexistentdoublecancer